International journal of pharmaceutics
Hyaluronic/Poloxamers-co-decorated nanoemulsion containing naringenin and quercetin for psoriasis treatment.
Ryan Fauzy, Fatimah Aqilah Az Zahro, Vania Maharani, Zaizafun Faiha, Angela Bilqisth, Syaiful Choiri
Published: 202610.1016/j.ijpharm.2026.126617
Abstract
Psoriasis is a chronic autoimmune disorder characterized by persistent inflammation that progressively impairs the quality of life. Conventional corticosteroids suppress inflammatory mediators but fail to inhibit immune cell activation, leading to ch…
Preview only. Read the full abstract at the source